drugset / Trial / NCT05212259
Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
RandomizedParallel-groupTriple-blindOther
Summary
A Randomized, Double-Blind, Placebo-controlled, Parallel Design Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion \& Joint Discomfort in Healthy Subjects
Timeline
- Start
- 2022-10-10
- Primary completion
- 2023-09-15
- Completion
- 2023-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Chondroitin sulphate | Unknown | — | — |
| Subject | Collagen type II | Unknown | 40 mg | — |
| Subject | Collagen type II | Unknown | 80 mg | — |
| Subject | Collagen type II | Unknown | 120 mg | — |
| Comparator | Glucosamine | Small molecule | — | — |